{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:13:50Z","timestamp":1793060030055,"version":"4.5.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiology Case Reports"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.radcr.2026.01.032","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T19:30:20Z","timestamp":1771011020000},"page":"1871-1875","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Severe neuro-beh\u00e7et\u2019s disease refractory: Radiologic improvement with tocilizumab"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-7123-3458","authenticated-orcid":false,"given":"Kaouthar","family":"Benyarou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9162-6905","authenticated-orcid":false,"given":"Sanae","family":"El hasnaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samah","family":"Yousfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yassine","family":"Mebrouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.radcr.2026.01.032_bib0001","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1093\/brain\/122.11.2171","article-title":"Clinical patterns of neurological involvement in Beh\u00e7et's disease: evaluation of 200 patients","volume":"122","author":"Akman-Demir","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.radcr.2026.01.032_bib0002","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2147\/JMDH.S93681","article-title":"Beh\u00e7et\u2019s syndrome: providing integrated care","volume":"10","author":"Esatoglu","year":"2017","journal-title":"J Multidiscip Healthc"},{"key":"10.1016\/j.radcr.2026.01.032_bib0003","doi-asserted-by":"crossref","unstructured":"Kural-Seyahi E, Fresko I, Seyahi N, Ozyazgan Y, Hamuryudan V, Yurdakul S, et al. The long-term mortality and morbidity of Beh\u00e7et syndrome: a 2-decade outcome survey of 387 patients. Medicine (Baltimore). doi:10.1097\/00005792-200301000-00006.","DOI":"10.1097\/00005792-200301000-00006"},{"issue":"4","key":"10.1016\/j.radcr.2026.01.032_bib0004","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.neurol.2011.09.006","article-title":"Neurological manifestations of Beh\u00e7et\u2019s disease: evaluation of 40 patients","volume":"168","author":"Ait Ben Haddou","year":"2012","journal-title":"Rev Neurol (Paris)"},{"issue":"6","key":"10.1016\/j.radcr.2026.01.032_bib0005","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1136\/annrheumdis-2018-213225","article-title":"2018 update of the EULAR recommendations for the management of Beh\u00e7et\u2019s syndrome","volume":"77","author":"Hatemi","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.radcr.2026.01.032_bib0006","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.semarthrit.2014.08.004","article-title":"Tocilizumab for severe refractory neuro-beh\u00e7et: three cases","volume":"44","author":"Addimanda","year":"2015","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.radcr.2026.01.032_bib0007","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1006\/clin.1996.4268","article-title":"Cerebrospinal fluid interleukin-6 in progressive neuro-Beh\u00e7et\u2019s syndrome","volume":"82","author":"Hirohata","year":"1997","journal-title":"Clin Immunol Immunopathol"},{"issue":"2","key":"10.1016\/j.radcr.2026.01.032_bib0008","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/09629350220131935","article-title":"Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 in patients with Beh\u00e7et\u2019s disease","volume":"11","author":"Evereklioglu","year":"2002","journal-title":"Mediators Inflamm"},{"issue":"6","key":"10.1016\/j.radcr.2026.01.032_bib0009","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.clineuro.2009.02.001","article-title":"CSF levels of cytokines in neuro-Beh\u00e7et\u2019s disease","volume":"111","author":"Borhani-Haghighi","year":"2009","journal-title":"Clin Neurol Neurosurg"},{"issue":"9","key":"10.1016\/j.radcr.2026.01.032_bib0010","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1007\/s00415-013-7209-3","article-title":"Diagnosis and management of neuro-Beh\u00e7et\u2019s disease: international consensus","volume":"261","author":"Kalra","year":"2014","journal-title":"J Neurol"},{"issue":"12","key":"10.1016\/j.radcr.2026.01.032_bib0011","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1136\/bjo.2007.124875","article-title":"Beh\u00e7et\u2019s disease: global epidemiology of an old silk road disease","volume":"91","author":"Keino","year":"2007","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.radcr.2026.01.032_bib0012","doi-asserted-by":"crossref","first-page":"223","DOI":"10.5152\/eurjrheum.2021.20160","article-title":"Use of non-TNF biologics for neuro-Beh\u00e7et\u2019s disease: literature review and two refractory cases treated with tocilizumab","volume":"8","author":"Karabulut","year":"2021","journal-title":"Eur J Rheumatol"},{"key":"10.1016\/j.radcr.2026.01.032_bib0013","doi-asserted-by":"crossref","unstructured":"Liu J, Yan D, Wang Z, Yang Y, Zhang S, Wu D, et al. Tocilizumab in the treatment of severe and refractory neuro-Beh\u00e7et\u2019s syndrome. Ther Adv Musculoskelet Dis 2020;12:1759720. doi:10.1177\/1759720x20971908. \u00d7 20964035.","DOI":"10.1177\/1759720X20971908"},{"issue":"3","key":"10.1016\/j.radcr.2026.01.032_bib0014","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.clineuro.2011.10.024","article-title":"Tocilizumab treatment for neuro-Beh\u00e7et\u2019s disease: the first report","volume":"114","author":"Shapiro","year":"2012","journal-title":"Clin Neurol Neurosurg"},{"issue":"Suppl 72","key":"10.1016\/j.radcr.2026.01.032_bib0015","first-page":"S73","article-title":"Refractory neuro-beh\u00e7et treated by tocilizumab: a case report","volume":"30","author":"Urbaniak","year":"2012","journal-title":"Clin Exp Rheumatol"}],"container-title":["Radiology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1930043326000300?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1930043326000300?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T12:57:15Z","timestamp":1773838635000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1930043326000300"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1930043326000300"],"URL":"https:\/\/doi.org\/10.1016\/j.radcr.2026.01.032","relation":{},"ISSN":["1930-0433"],"issn-type":[{"value":"1930-0433","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Severe neuro-beh\u00e7et\u2019s disease refractory: Radiologic improvement with tocilizumab","name":"articletitle","label":"Article Title"},{"value":"Radiology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radcr.2026.01.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of University of Washington.","name":"copyright","label":"Copyright"}]}}